drug
safinamide mesylate
Marketedupdated 3mo agoby Zenara Pharma Pvt Ltd
Approvedcommunity read0 votes
indications
investigational
Parkinson's Disease
all catalysts(0)
nothing on the calendar yet
Patent cliff
source: FDA Orange Bookfirst barrier falls
Jun 8, 2027
319 days
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (6)
- Mar 21, 2031method-of-use (U-1993)US 82833804.7y
- Mar 21, 2031method-of-use (U-1993)US 82833804.7y
- Dec 10, 2028compositionUS 80765152.4y
- Dec 10, 2028compositionUS 80765152.4y
- Jun 8, 2027compositionUS 8278485319d
- Jun 8, 2027compositionUS 8278485319d
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that